Ksilink proudly announces the publication of exciting results in the journal “Cancer Biology & Therapy”. In fact, the technology for Personalized Functional Profiling (PFP) of...
A l'occasion de la journée de l'amitié franco-allemande, Ksilink vous présente ses meilleurs vœux pour l'année 2022 ! Version française Anlässlich des Tages der...
What you see here is neither a virtual firework nor has Ksilink become an expressionist. We took this beautiful picture, figuring the AI-based analysis of the pharmacological...
Ksilink is happy to announce the initiation of the ANR funded project "Target-agnostic drug discovery approaches for neuromuscular diseases (TREAD)". This project is supporting...
Ksilink is happy to have welcomed the team of Prof. Valérie Mezger-Lallemand from Université Didérot to initiate a collaboration with the aim to establish a new patient-based disease model to identify …
We are proud to be present with two posters during the AI powered Drug Discovery Symposium from 8-9th of November 2021 in London, at Francis Crick Institute. Download our poster...
We are happy to welcome you on our new website. We will keep you informed about news and activities around patient-based drug discovery. Come and visit us on www.ksilink.com !!
Ksilink is pleased to share with you this virtual tour of its partner CECS I-Stem with the following message of its founder and scientific director Marc Peschanski: “Dear...
Ksilink is happy to be part of the Strasbourg Boston Initiative 2020 ! At Ksilink we use every day as an opportunity to not only create new and efficient ways to work smarter but...
